Search
Our Services - Cacer Care at Halifax Health
Back

Clinical Cancer Details

Protocol No.: GENENTECHAVF3671g
Title: A randomized, double-blind, placebo-controlled, phase IIIb trial comparing Bevacizumab therapy with or without Erolotinib after completion of chemotherapy with Bevacizumab for the first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer.
Staging: Extensive Disease,
Objective:
Overview:
Eligibility Requirements:
No. Requirement
1This Protocol has Complex eligibility criteria. Please contact us for further information: Contact Name: Beverly Shook, RN, OCN, CCRP, Contact Phone: (386) 254-4211, Contact Email: beverly.shook@halifax.org
Contact: Regional Oncology Center
303 N. Clyde Morris Blvd., Daytona Beach, Florida 32114
Debbie Reynolds, RN, OCN
(386) 254-4213

Regional Oncology Center
303 N. Clyde Morris Blvd., Daytona Beach, Florida 32114
Beverly Shook
(386) 254-4213
Copyright 2012 Halifax Health. All Rights Reserved
Privacy Policy | Financial Information | Terms of Use
Under Florida law, e-mail addresses are public records. If you do not want your e-mail address released in response to a public records request, do not send electronic mail to this entity. Instead, contact us by phone or in writing.